• Investor Toby Neugebauer has launched a campaign at Fermi (NasdaqGS:FRMI) calling for a special meeting to elect a new independent board majority.
• The campaign is also pushing for a 75 day dual track review that would weigh a sale or partnership alongside a refreshed standalone plan.
• This rise in shareholder activism points to potential changes in Fermi’s governance and long term direction that current and prospective shareholders will want to follow closely.

Fermi’s latest activism push comes with the stock at $6.6, after a gain of 2.6% over the past week and 27.7% over the past month, while the share price is still down 25.2% year to date. For a company where long term return data is not yet available, moves like this often put governance and capital allocation under a brighter spotlight for investors tracking NasdaqGS:FRMI.

For you as a shareholder or potential buyer, the key question is how any board changes and dual track review might affect Fermi’s options, including partnerships, a potential sale, or a refreshed standalone roadmap. The coming weeks could bring more detail on the process, giving you more information to evaluate how Fermi’s leadership intends to respond to this pressure.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Quick Assessment

• ✅ Price vs Analyst Target: At US$6.60, Fermi trades about 68% below the US$20.50 analyst price target.
• ✅ Simply Wall St Valuation: Model suggests the stock trades around 98.3% below its estimated fair value.
• ✅ Recent Momentum: The share price is up 27.7% over the past 30 days.

There is only one way to know the right time to buy, sell or hold Fermi. Head to Simply Wall St's company report for the latest analysis of Fermi's Fair Value.

Key Considerations

• 📊 The activism push for a new board and dual-track review could influence whether Fermi continues alone, seeks a partner, or considers a sale.
• 📊 Watch how the board responds, any timetable for the 75 day review, and whether management updates guidance or capital plans during this process.
• ⚠️ Fermi currently reports less than US$1m in revenue, so execution risk is high if the review disrupts plans without a clear operating path.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Fermi analysis. Alternatively, you can check out the community page for Fermi to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.